Clinical Trial Update: Human Milk Fortification in Extremely Preterm Infants [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 clinical trial evaluating human milk fortification in extremely preterm infants; the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Sepsis

Snippet

Sponsor: Thomas Abrahamsson, MD, PhD | Conditions: Necrotizing Enterocolitis, Sepsis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING